Pathologic Classification of Focal Segmental

By Vivette D’Agati

Focal segmental glomerulosclerosis (FSGS) is defined as a clinical-pathologic syndrome manifesting and focal and segmental glomerular sclerosis with foot process effacement. The pathologic approach to the classification of FSGS is complicated by the existence of primary (idiopathic) forms and multiple subcategories with etiologic associations, including human immunodeficiency virus (HIV)-associated nephropathy, heroin ne- phropathy, familial forms, drug toxicities, and a large group of secondary FSGS mediated by structural-functional adaptations to glomerular hyperfiltration. A number of morphologic variants of primary and secondary focal sclerosis are now recognized, including FSGS not otherwise specified (NOS), perihilar, cellular, tip, and collapsing variants. The defining features of these morphologic variants and of the major subcategories of FSGS are discussed with emphasis on distinguishing light microscopic patterns and clinical-pathologic correlations. © 2003 Elsevier Inc. All rights reserved.

HE FIRST IMAGE of focal segmental glo- tern of sclerosis evolves. Alterations of the podo- Tmerulosclerosis (FSGS) was published in cyte cytoarchitecture constitute the major ultra- 1925 in a remarkably accurate drawing by Fahr1 structural findings. from an atlas of human pathology. Even at that The approach to a diagnosis of FSGS is prob- early time, Fahr1 recognized the relatedness of this lematic because the morphologic features are non- novel lesion to when he specific and can occur in a variety of other condi- aptly entitled it lipoid with degeneration. tions or superimposed on other glomerular It would be another 32 years before Rich2 provided processes.6 In addition, because the defining glo- a more detailed pathologic description of focal merular lesion is focal, it may not be adequately sclerosis in autopsy specimens of children dying sampled in small needle biopsies. with caused by apparent lipoid The diagnosis of FSGS is further complicated by nephrosis. Rich2 was the first to observe the pref- the existence of a primary (or idiopathic) form and erential distribution of the segmental sclerosing many secondary forms (Table 1).6,7 Before a diag- lesions in juxtamedullary glomeruli early in the nosis of primary FSGS can be reached, secondary disease, indicating the focality of the sclerosing forms must be carefully excluded. Idiopathic FSGS process. He postulated that the development of must be distinguished from human immunodefi- sclerosis probably accounted for the progression to ciency virus (HIV)-associated nephropathy and renal failure seen in a subset of children with heroin nephropathy, as well as the large group of secondary FSGS caused by structural-functional idiopathic nephrotic syndrome. However, it was adaptations mediated by intrarenal vasodilatation not until the 1970s, in a report by the International and by increased glomerular capillary pressures Study of Diseases in Children, that focal and plasma flow rates.7 Such maladaptive glomer- segmental glomerulosclerosis emerged as a sepa- ular hemodynamic alterations can arise through: rate clinical-pathologic entity that was distin- (1) a reduction in the number of functioning guished from minimal change disease by its greater (such as after unilateral renal agenesis, steroid resistance and progression to renal failure.3 surgical ablation, oligomeganephronia, or any ad- Over the past 30 years, concepts of FSGS have vanced primary renal disease), or (2) mechanisms been refined in more detailed clinical-pathologic that place hemodynamic stress on an initially nor- studies from many centers. FSGS is defined as a mal population (as in morbid obesity, clinical-pathologic syndrome manifesting protein- cyanotic congenital heart disease, and sickle cell uria, usually of nephrotic range, associated with lesions of focal and segmental glomerular sclerosis From the Department of Pathology, Columbia University, 4,5 and foot process effacement. Although hyaline College of Physicians and Surgeons, New York, NY. insudation is common, the condition lacks glomer- Address reprint requests to Vivette D’Agati, MD, Department ular immune complex deposits. Early in the disease of Pathology, Columbia University, College of Physicians and process, the pattern of glomerular sclerosis is focal, Surgeons, 630 West 168th St, New York, NY 10032. involving a subset of glomeruli, and segmental, E-mail: [email protected] © 2003 Elsevier Inc. All rights reserved. involving a portion of the glomerular tuft. As the 0270-9295/03/2302-0002$30.00/0 disease progresses, a more diffuse and global pat- doi:10.1053/snep.2003.50012

Seminars in , Vol 23, No 2 (March), 2003: pp 117-134 117 118 VIVETTE D’AGATI

Table 1. Etiologic Classification of FSGS scarring in the course of other primary glomerular diseases (such as chronic , dia- Primary (idiopathic) FSGS C1q nephropathy betic glomerulosclerosis, membranous glomeru- HIV-associated nephropathy lopathy, hereditary , and so forth). Five Heroin nephropathy main light microscopic patterns of FSGS have Familial FSGS been defined, including FSGS (not otherwise spec- ␣ Mutations in -actinin 4 (autosomal dominant) ified [NOS]), perihilar variant, cellular variant, tip Mutations in podocin (autosomal recessive) Mitochondrial cytopathies variant, and collapsing variant. Although the ap- Drug toxicity pearance of the glomerular tuft differs in these Pamidronate forms, all share the common feature of podocyte Lithium alterations at the ultrastructural level. At the ␣ Interferon- present time, it is unclear if these morphologic Secondary FSGS (adaptive structural-functional response likely mediated by glomerular variants reflect pathogenetic differences or whether hypertrophy/hyperfiltration) they are the consequence of different severities of Reduced renal mass podocyte injury or tempos of histopathologic evo- Oligomeganephronia lution. Future studies are needed to address these Unilateral renal agenesis questions. The pathologic features and major clin- Renal dysplasia Reflux nephropathy ical correlates of each of these morphologic vari- Sequela to cortical necrosis ants are discussed. Surgical renal ablation Any advanced renal disease with reduction in FSGS (NOS) functioning nephrons FSGS (NOS) constitutes the generic lesion of Chronic allograft nephropathy Initially normal renal mass FSGS. The synonyms classic FSGS or FSGS of the mellitus usual type often are applied. This category requires Hypertension that other morphologic categories (perihilar, cellu- Obesity lar, tip, and collapsing) be excluded. FSGS (NOS) Cyanotic congenital heart disease is the most common morphologic pattern of FSGS. Sickle cell anemia Nonspecific pattern of FSGS caused by renal scarring Evidence from repeat biopsy examinations sug- Focal proliferative glomerulonephritis (IgA gests that other variants may evolve into this pat- nephropathy, nephritis, pauci-immune focal tern in the course of disease progression and in- necrotizing and crescentic glomerulonephritis) creasing chronicity. Hereditary nephritis Pathologic Features Hypertensive arterionephrosclerosis Membranous FSGS (NOS) is defined as a discrete segmental Thrombotic microangiopathies consolidation of the glomerular tuft by increased extracellular matrix, causing obliteration of the glomerular capillary lumen/lumina (Figs 1A–1B). anemia). Finally, primary and secondary FSGS Early in the disease, the segmental lesions have a also must be differentiated from the nonspecific predilection for the juxtamedullary glomeruli. Le- pattern of focal and segmental glomerular scarring sions of sclerosis can affect the perihilar (ie, vas- that can follow a variety of inflammatory, prolif- cular pole) region or the periphery of the tuft. In erative, thrombotic, and hereditary conditions. some glomeruli, segmental lesions may affect FSGS comprises a number of morphologic sub- more than one lobule, involving both the perihilar types that may have different prognostic and ther- and peripheral regions. According to one study apeutic implications. These morphologic variants using serial sections, peripheral lesions tend to be were defined at a recent consensus conference of more common in childhood FSGS than the adult renal pathologists in New York City (Table 2). The disease.8 Any number of glomeruli can be affected categorization outlined in Table 2 encompasses the by segmental sclerosis, with or without associated spectrum of primary FSGS, as well as some sec- global sclerosis. ondary forms. This schema presumes prior exclu- Glomerular capillaries are occluded segmentally sion of secondary FSGS caused by glomerular by relatively acellular matrix material, often asso- PATHOLOGIC CLASSIFICATION OF FSGS 119

Table 2. Morphologic Variants of FSGS

Variant Positive Criteria Negative Criteria

FSGS (NOS) At least one with segmental increase in matrix Exclude perihilar, cellular, tip, and obliterating the capillary lumina collapsing variants There may be segmental glomerular basement membrane collapse without podocyte hyperplasia Perihilar variant Perihilar sclerosis and hyalinosis involving Ͼ50% of Exclude cellular, tip, and collapsing segmentally sclerotic glomeruli variants Cellular variant At least one glomerulus with segmental endocapillary Exclude tip and collapsing variants hypercellularity occluding lumina, with or without foam cells and karyorrhexis Tip variant At least one segmental lesion involving the tip domain Exclude collapsing variant (outer 25% of tuft next to origin of proximal tubule) Exclude any perihilar sclerosis The tubular pole must be identified in the defining lesion The lesion must have either an adhesion or confluence of podocytes with parietal or tubular cells at the tubular lumen or neck The tip lesion may be sclerosing or cellular Collapsing variant At least one glomerulus with segmental or global collapse None and podocyte hypertrophy/hyperplasia

ciated with inframembranous hyalinosis, endocap- The number of glomeruli affected by segmental illary foam cells, and wrinkling of glomerular lesions depends on the severity of the disease pro- basement membrane (GBM). Hyalinosis, also cess and the number of serial sections examined. known as plasmatic insudation, consists of the As the lesions evolve globally, there is progression accumulation beneath the GBM of amorphous to complete glomerular obsolescence. Lobules un- glassy material that is eosinophilic, nonargyro- affected by the segmental sclerosis usually appear philic, and trichrome-red (Fig 1B). Clear lipid normal by light microscopy but for mild swelling vacuoles may be entrapped in the hyaline material. of the podocytes. There often is continuity between the glomerular There is typically patchy tubular atrophy and hyalinosis and hyalinosis involving the contiguous interstitial fibrosis commensurate with the severity afferent arteriole. There may be segmental GBM and distribution of the glomerular sclerosis. Prox- collapse without podocyte hypertrophy or hyper- imal tubules frequently contain intracellular lipid plasia. Mesangial hypercellularity and glomerulo- and protein resorption droplets (Fig 1C). Interstitial megaly may be present. Mesangial hypercellularity foam cells may be identified, either as isolated cells is more prevalent in pediatric FSGS, especially or aggregates. early in the disease course.9-11 In some cases, there is disproportionately severe Adhesions or synechiae to Bowman’s capsule tubulointerstitial damage relative to the degree of are common. The overlying visceral epithelial cells glomerular sclerosis. In such cases, the tubules often appear swollen and can form a cellular cap may display degenerative and regenerative over the sclerosing segment (Fig 1B). Detachment changes including epithelial simplification, en- of podocytes from the sclerosing segment with larged hyperchromatic nuclei, and nucleoli. Such intervening accumulation of newly formed matrix damage tends to be more common in cases with material may produce an apparent halo of weakly severe unremitting nephrotic syndrome in which periodic-acid Schiff (PAS)-positive or weakly long-standing heavy proteinuria itself is likely to trichrome blue-positive matrix between the scle- mediate the progressive tubulointerstitial damage. rosed segment and the detached podocytes (Fig Evidence from human and animal studies indicates 1B). There is no restriction on the degree of podo- that increased protein trafficking through tubular cyte hypertrophy and hyperplasia seen in FSGS reabsorption of filtered protein promotes progres- (NOS) provided that these podocyte alterations do sive tubulointerstitial damage.12,13 Protein over- not affect collapsed capillaries. load of tubular cells leads to increased tubular 120 VIVETTE D’AGATI

Fig 1. Light and fluorescence microscopic findings in FSGS (NOS), FSGS, perihilar variant and FSGS, cellular variant. (A) FSGS (NOS): Low power view showing segmental sclerosis involving many glomeruli. The lesions of segmental sclerosis are discrete and readily distinguished from the adjacent preserved portions of the tuft. In this example, there is no evidence of tubular atrophy. (Jones methenamine silver; JMS). (B) FSGS (NOS): Trichrome stain helps to distinguish the wrinkled and retracted glomerular basement membranes, shown in blue, from the red-staining hyaline insudation. There is detachment and capping of the overlying podocytes, with a halo-like zone of pale neomembrane overlying the site of detachment. (C) FSGS (NOS): The tubules contain abundant intracyto- plasmic protein resorption droplets that stain red and blue with the trichrome stain. (D) FSGS (NOS): By immuno- fluorescence, there is segmental staining for IgM involving the sclerotic portion of the tuft, with weaker mesangial positivity involving the adjacent nonsclerotic segments. (E) FSGS, perihilar variant: The lesion of segmental sclerosis and hyalinosis is located at the glomerular vascular pole, or hilus, which is identified by the presence of the juxtaglomerular apparatus with macula densa. The hyalinosis appears glassy and eosinophilic. There is no podocyte reactivity. (Hematoxylin and eosin; H&E). (F) FSGS, cellular variant: The glomerular capillary lumina are segmentally obliterated by endocapillary hypercellularity including numerous infiltrating leukocytes, resembling a proliferative glomerulonephritis. There is hypertrophy of the overlying podocytes. (H&E). PATHOLOGIC CLASSIFICATION OF FSGS 121 expression of chemokines such as monocyte che- sclerotic segments (Fig 4C). In these areas, inter- moattractant protein-1 and osteopontin that in turn vening accumulation of lamellated neomembrane attract inflammatory cells to the interstitium and material commonly is observed between the naked lead to enhanced expression of fibrogenic cyto- GBM and the retracted podocyte cell body (Fig kines that promote interstitial fibrosis. Tubular syn- 4C). These foci of detachment correspond to the thesis of endothelin-1 also may contribute to inter- halos observed by light microscopy surrounding stitial fibrosis by local vasoconstrictive effects and the sclerosing segments. resultant ischemic injury.13 The major ultrastructural finding involving non- By immunofluorescence, there is typically focal sclerotic glomerular capillaries is foot process ef- and segmental granular deposition of immunoglob- facement. The degree of foot process fusion ob- ulin (Ig)M, C3, and, more variably, C1 in the served overlying these open capillaries varies from distribution of the segmental glomerular sclerosis mild to severe, but usually involves greater than and hyalinosis (Fig 1D). More generalized weak 50% of the total glomerular capillary surface area. (Ͻ2ϩ) mesangial deposition of IgM also may be In general, the degree of fusion correlates roughly present (Fig 1D). Staining for albumin and some with the severity of the proteinuria, such that pa- immunoglobulins (particularly IgA as well as IgG) tients with subnephrotic proteinuria tend to have may be found within the podocytes, corresponding less foot process fusion than those who are fully to intracytoplasmic protein resorption droplets. nephrotic. In the areas of foot process effacement, One should be careful to distinguish this intracel- there usually is loss of recognizable slit dia- lular staining from immune deposits within the phragms and mat-like condensations of cytoskel- glomerular tuft itself. Similarly, intracytoplasmic etal filaments oriented parallel to the direction of deposits of albumin, immunoglobulins, and some- the GBM itself. Thus, although the lesions of times C3 may be found involving proximal tubules FSGS are focal at the light microscopic level, the that are engaged in active protein resorption. podocyte alterations are relatively diffuse at the By electron microscopy, the lesions of segmen- electron microscopic level. tal sclerosis display wrinkling and retraction of GBM and accumulation of inframembranous hya- Clinical-Pathologic Correlations line, with resulting narrowing or occlusion of the The most prognostically significant clinical fea- glomerular capillary lumina (Fig 4A). The electron tures in FSGS are serum creatinine and the severity dense hyaline material is usually more waxy in of proteinuria at presentation.14 The presence of appearance than true immune complex deposits nephrotic proteinuria (Ͼ3.0–3.5 g/d) has been as- and tends to pool beneath the GBM, conforming to sociated with a worse outcome in primary FSGS, the contours of the delimiting membrane. Hyaline with mean time course to end-stage renal disease deposits frequently contain curvilinear membra- of 6 to 8 years.14 This is compared with over 80% nous particles or entrapped electron lucent lipid 10-year renal survival in patients with nonne- globules. Endocapillary foam cells appear as large phrotic proteinuria. Not surprisingly, severe pro- intracapillary cells containing abundant electron teinuria of over 10 g/d is associated with an even lucent vacuoles (Fig 4A). more rapid course to renal failure (Ͻ3 y).15,16 Directly overlying the lesions of segmental scle- Prognosis is better in those who undergo a remis- rosis there usually is complete effacement of foot sion of nephrotic syndrome than those with persis- processes, accompanied by podocyte alterations tent nephrotic syndrome. Most studies agree that that include hypertrophy, increased organellar con- the best pathologic predictor of poor outcome is tent, and focal microvillous transformation. This the degree of interstitial fibrosis.17-20 Interestingly, microvillous appearance is caused by the forma- the percentage of glomeruli with segmental scars tion of slender cellular projections resembling villi or global sclerosis has not been found to be inde- along the surface of the podocytes facing the uri- pendently predictive of outcome. nary space. The hypertrophied podocytes display FSGS (NOS) accompanied by mesangial hyper- rounded cell bodies that adhere smoothly to the cellularity is most common in the pediatric age GBM, with frequent loss of primary processes. group. Studies by Yoshikawa et al9 and by the There may be detachment of podocytes from the Southwest Pediatric Nephrology Study Group10 in sclerosing segment (Fig 4B), as well as from non- 57 and 75 patients, respectively, did not show 122 VIVETTE D’AGATI prognostic import of diffuse mesangial hypercellu- cellular FSGS requires that tip and collapsing vari- larity occurring in idiopathic FSGS. The only cor- ant be excluded. relation reported by the Southwest Pediatric Ne- phrology Study Group study was a shorter time Pathologic Features course from clinical presentation to biopsy exam- The cellular variant is defined by the presence of ination in the patients with FSGS and diffuse mes- at least one glomerulus with segmental endocapil- angial hypercellularity compared with FSGS with- lary hypercellularity involving at least 25% of the out mesangial hypercellularity.10 Thus, similar to tuft and causing occlusion of the capillary lumen/ cellular FSGS, the presence of diffuse mesangial lumina (Fig 1F). Any segment (perihilar or periph- hypercellularity in FSGS (NOS) appears to repre- eral) may be affected. When numerous glomeruli sent an early stage in the development of FSGS but are affected, the process may mimic focal prolif- does not correlate with outcome. Therefore, the erative glomerulonephritis.6 The lesions of endo- consensus conference concluded that the presence capillary hypercellularity typically are expansile, of diffuse mesangial hypercellularity in FSGS did causing engorgement of the glomerular capillaries. not warrant a separate morphologic classification. The endocapillary cells may include endothelial cells, foam cells, and infiltrating leukocytes, in- FSGS, PERIHILAR VARIANT cluding monocyte/macrophages (Fig 1F). Other This category requires that the cellular variant, leukocytes, including lymphocytes and neutro- tip variant, and collapsing variant be excluded. It is phils, also may be present. Some of these lesions defined by the presence of perihilar sclerosis and are accompanied by foamy hyaline material, fibrin, hyalinosis involving greater than 50% of segmen- and karyorrhexis, resembling segmental necrotiz- tally sclerotic glomeruli (Fig 1E). Glomerulo- ing lesions, but without rupture of GBM. megaly and adhesions are common. There often is Although the cellular variant is defined by the arteriolar hyalinosis, sometimes in continuity with presence of segmental endocapillary hypercellular- hyalinosis in the perihilar segment. Foam cells may ity, it also frequently displays extracapillary hyper- be entrapped in the sclerotic lesions. Podocyte cellularity owing to hyperplasia of the podocytes. hypertrophy and hyperplasia may be present but Podocytes may appear swollen and crowded, some- typically are less frequent than in the other vari- times forming pseudocrescents. These pseudo- ants. Other glomeruli may show lesions of segmen- crescents usually can be distinguished from true tal and/or global glomerulosclerosis, as described crescents by their lack of attachment to Bowman’s for FSGS (NOS) earlier. Immunofluorescence and capsule or continuity with the parietal epithelial ultrastructural findings are similar to those de- cells. Moreover, the extracapillary cells tend to be scribed in the section on FSGS (NOS). plump, rounded, and poorly cohesive, with fre- quent intracellular protein resorption droplets. Clinical-Pathologic Correlations These extracapillary cells lack the spindled mor- phology or pericellular matrix typically observed This variant of FSGS may occur in primary in true crescents. Another distinguishing feature is FSGS. However, when accompanied by glomeru- that Bowman’s capsule itself is intact, without the lomegaly, it is particularly common in patients ruptures typical of cellular crescents of the inflam- with secondary forms of FSGS mediated by an matory type. adaptive response to increased glomerular capil- In some cases, cellular lesions are identified in lary pressures and flow rates (as in association with all affected glomeruli, whereas in others they affect obesity, cyanotic congenital heart disease, reflux a minority of glomeruli, possibly reflecting differ- nephropathy, renal agenesis, dysplasia, oligomega- ent stages in the evolution of sclerosis. Other glo- nephronia, or any advanced renal disease with a meruli may contain lesions of segmental or global reduced number of functioning nephrons; see dis- glomerulosclerosis of the usual type, as described cussion of secondary forms of FSGS later). for FSGS (NOS). By immunofluorescence there is focal and seg- FSGS, CELLULAR VARIANT mental glomerular positivity for IgM and C3. At The cellular variant of FSGS was first described the ultrastructural level, the cellular variant usually by Schwartz and Lewis21 in 1985. A diagnosis of displays severe foot process effacement, correlat- PATHOLOGIC CLASSIFICATION OF FSGS 123 ing with the generally high levels of proteinuria Pathologic Features (Fig 4D). Cellular lesions consist of segmental As defined originally by Howie and Brewer,24 occlusion of glomerular capillaries by endocapil- the early lesion is characterized by confluence of lary hypercellularity including foam cells and swollen, hypertrophied visceral epithelial cells monocytes (Figs 4E and 4F). The GBM is intact, with parietal or tubular epithelial cells at the tubu- without evidence of rupture. lar pole. The affected lobule may display endocap- Clinical-Pathologic Correlations illary hypercellularity with endocapillary foam cells and hyalinosis. In some cases, the affected Compared with FSGS (NOS), the cellular vari- segment appears to herniate into the tubular lumen ant is characterized by more severe proteinuria and (Fig 2B). As the lesion evolves, there is adhesion a shorter time course from clinical onset of renal of the glomerular tuft to Bowman’s capsule at the disease to biopsy examination, suggesting an early point of transition to the proximal tubular base- 21 phase in the evolution of the segmental sclerosis. ment membrane (Fig 2A).24 Later lesions may 21 Schwartz and Lewis found a shorter interval be- form segmental scars. tween onset of proteinuria (3.4 versus 71.9 mo) in Other glomeruli may show segmental sclerosis patients with cellular versus classic FSGS. More- or endocapillary hypercellularity in the periphery over, 90% of patients in the cellular group had but not involving the tip, or in a portion of the tuft urine protein levels greater than 3 g/d, compared that cannot be identified as tip or perihilar. How- with 49% of those without cellular lesions. Simi- ever, the presence of segmental sclerosis or endo- larly, the incidence of full nephrotic syndrome at capillary hypercellularity in a perihilar location presentation was significantly higher (70% versus rules out the tip variant of FSGS. Global sclerosis 23%). Indeed, patients with cellular FSGS often may be present. have a very abrupt onset of severe nephrotic syn- The segmental lesions usually stain for IgM and drome resembling the presentation of minimal C3 by immunofluorescence. But for their location change disease (personal observations). Repeat bi- at the tubular pole, the lesions often resemble those opsy examinations in some cases have shown evo- of cellular FSGS at the ultrastructural level. lution to more typical segmental scars, supporting the concept that the hypercellularity is an early Differential Diagnosis stage in the development of the segmental sclero- sis. A similar evolution from cellular to more scle- Tip lesions are not specific, but may occur in the rosing lesions has been documented by repeat biopsy setting of a variety of glomerular diseases includ- examination in recurrent FSGS in the transplant.22 ing membranous glomerulopathy, IgA nephropa- 25 The cellular variant may be responsive to im- thy, diabetic glomerulosclerosis, and others. munosuppressive therapy.23 This favorable treat- Thus, the designation of glomerular tip lesion ment response probably relates to the early and should be applied only to those cases with glomer- relatively active stage of glomerular injury in the uli that look otherwise like minimal change disease cellular variant. or focal segmental glomerulosclerosis, and in which other glomerular conditions have been FSGS, TIP VARIANT excluded. The tip variant of FSGS is defined by the pres- Clinical-Pathologic Correlations ence of at least one glomerulus with a segmental lesion involving the tip domain (ie, the peripheral It is uncertain how the pathogenesis of tip lesion 25% of the glomerular tuft next to the origin of the may differ, if at all, from that of the more classic proximal tubule). There must be either adhesion lesions of FSGS. A study of autopsy kidneys from between the tuft and Bowman’s capsule at the children dying with minimal change disease in the tubular lumen or neck, or confluence of podocytes presteroid era revealed focal tip lesions in a small with parietal epithelial or tubular epithelial cells at percentage of glomeruli.26 This study concluded the tubular pole or neck (Figs 2A–2B). The prox- that tip lesions may arise as a nonspecific response imal tubular pole must be identified in the defining of the peritubular segment of the glomerular tuft to glomerulus. The designation of tip lesion requires fluxes of protein-rich filtrate in the setting of ne- that the collapsing variant be excluded. phrotic syndrome. 124 VIVETTE D’AGATI

Fig 2. Light microscopic findings in FSGS, tip variant and FSGS, collapsing variant. (A) FSGS, tip variant: There is a segmental lesion with endocapillary foam cells that forms an adhesion to Bowman’s capsule at the origin of the tubular pole. The podocytes are capped over this segment and merge with the tubular epithelial cells. (Periodic-acid Schiff, PAS). (B) FSGS, tip variant: A segmental lesion herniates into the tubular pole. The tip zone is engorged with endocapillary foam cells and forms an adhesion to Bowman’s capsule at the tubular origin. There is confluence of the podocytes and the tubular epithelial cells surrounding the tip lesion. (Jones methenamine silver, JMS). (C) FSGS, collapsing variant: The glomerular collapse is diffuse and global in distribution, with associated severe tubular degenerative changes, (JMS). (D) FSGS, collapsing variant: In the collapsed tuft, the glomerular basement membranes are imploded, without appreciable increase in matrix material. The podocytes overlying the collapsed tuft are marked hyperplastic with enlarged vesicular nuclei, focal binucleated forms, and crowding of the urinary space. At the periphery, some of the podocytes appear to be falling off into the urinary space (JMS). (E) FSGS, collapsing variant: Immunostaining for proliferation marker Ki-67 (MIB1) shows many cycling cells in the urinary space, including visceral and parietal cells, as well as adjacent tubular epithelial cells, (Immunoperoxidase). (F) FSGS, collapsing variant: Trichrome stain delineates the collapsed blue-staining tuft and the abundant hyperplastic podocytes forming a pseudocrescent containing many intracytoplasmic fuchsinophilic protein resorption droplets. The podocyte hyperplasia lacks the spindled cellular morphology and pericellular matrix seen in true crescents of parietal cell origin. PATHOLOGIC CLASSIFICATION OF FSGS 125

The relationship of tip lesion to minimal change Pathologic Features disease and FSGS has been hotly debated. Whereas Collapsing FSGS presents a dramatic pattern of some groups have reported a greater likelihood of injury. Glomerular capillary lumina are occluded steroid responsivity and excellent long-term prog- by an implosive wrinkling and collapse of the nosis resembling that of minimal change disease, GBMs that is more often global than segmental, others have described an evolution toward more without predilection for the perihilar segments typical FSGS.27 Indeed, repeat biopsy examina- (Figs 2C–2D). This GBM collapse is best delin- tions in some of these patients have shown pro- eated with the use of the PAS or the Jones methe- gression to focal segmental and global glomerulo- namine silver stains (Figs 2C and 2D). The acute sclerosis with development of renal failure. nature of the glomerular injury is evidenced by the Recently, Hogan-Moulton et al28 described 80% lack of appreciable increase in intracapillary or steroid responsivity in glomerular tip lesion com- mesangial matrix. pared with 33% in FSGS, but with similar long- The glomerular collapse must be accompanied term renal survival (87% at 4 years in both groups). by striking hypertrophy and hyperplasia of the Clearly, evaluation of larger series of patients will overlying podocytes, which have enlarged, open be required to determine the significance of this vesicular nuclei with frequent nucleoli, occasional lesion. binucleated forms, and rare mitotic figures (Fig 2D). Proliferation marker Ki-67 (MIB1) is fre- FSGS, COLLAPSING VARIANT quently positive in the distribution of the podo- The designation of collapsing variant (also cytes, indicating that they are cell-cycle engaged known as collapsing glomerulopathy) is applied to (Fig 2E).33 Podocytes may be so crowded as to fill cases of FSGS in which at least one glomerulus the urinary space, forming pseudocrescents, and displays segmental or global obliteration of the often contain prominent intracytoplasmic protein glomerular capillary lumina by wrinkling and col- resorption droplets (Fig 2F). lapse of GBMs associated with podocyte hypertro- In collapsing FSGS, the podocyte displays a phy and hyperplasia. Collapse involving a single dysregulated phenotype with increased rates of glomerulus is considered significant, such that the proliferation and apoptosis.33 Podocytes normally presence of any glomerular collapse pre-empts the are endowed with high levels of constitutive ex- other morphologic categories of FSGS. pression of cyclin kinase inhibitors to safeguard The term glomerular collapse was first intro- against easy entry into the cell cycle that might duced by Weiss et al29 in 1986 to describe an jeopardize the cell’s ability to maintain its highly unusual clinicopathologic complex of severe ne- differentiated cytoarchitecture. However, in col- phrotic syndrome, rapidly progressive renal fail- lapsing FSGS, this system is perturbed, leading to ure, and glomerular collapse occurring in 6 black structural deterioration. The injured podocytes ex- patients. Two patients required dialysis within hibit reduced expression of cyclin kinase inhibitors 10 weeks of clinical presentation and 5 had an p27 and p57, promoting permissive cellular prolif- ill-defined febrile illness. Although the clinical eration.34,35 As the cells enter the cell cycle they and pathologic findings suggested possible HIV- lose their mature podocyte markers (such as syn- associated nephropathy, only one of these pa- aptopodin, WT-1, GLEPP-1, C3b receptor, and tients subsequently developed acquired immune CALLA).33 Transdifferentiation of podocytes to deficiency syndrome. Two subsequent series macrophage/monocytes also has been de- have reported a similar malignant course to renal scribed.36,37 The podocytes become less cohe- failure in patients with collapsing FSGS who sive, round up, and may actually detach and shed lack HIV infection.30,31 The incidence of the into the urinary space.37 Thus, in collapsing collapsing variant is increasing. Collapsing FSGS podocytes appear to lose their highly dif- FSGS comprised 11% of all primary FSGS at ferentiated cytoarchitecture through activation Columbia Presbyterian Medical Center from of a genetic program that involves re-entry into 1979 to 1985, 20% from 1986 to 1989, and 24% the cell cycle, disruption of the cytoskeleton, and from 1990 to 1993.31,32 cellular dedifferentiation. 126 VIVETTE D’AGATI

Collapsing FSGS is distinguished from the cel- ing lesions in the underlying tuft and breaks in the lular form by the absence of endocapillary hyper- GBM. cellularity. In fact, there is often an apparent re- duction in the number of glomerular endothelial Clinical-Pathologic Correlations cells in collapsed lobules. Unlike FSGS (NOS), Once a diagnosis of collapsing FSGS has been glomeruli with collapsing sclerosis usually lack reached, the possibility of HIV-associated ne- hyalinosis, endocapillary foam cells, and adhesions phropathy must be ruled out. Exclusion of HIV- to Bowman’s capsule. Mesangial hypercellularity, associated nephropathy is based on the demonstra- glomerulomegaly, and arteriolar hyalinosis are un- tion of negative HIV serologies, and is supported common. by the absence of endothelial tubuloreticular inclu- Tubulointerstitial disease is an important com- sions. ponent of this condition and often appears out of When compared with patients with FSGS (NOS) proportion to the degree of glomerular sclerosis. In or classic FSGS, patients with idiopathic collaps- addition to tubular atrophy, interstitial fibrosis, ing FSGS are more likely to be black and to edema, and inflammation, there are widespread present with more severe markers of nephrotic tubular degenerative and regenerative changes.31 syndrome, including more severe proteinuria, hy- These include tubular epithelial simplification with poalbuminemia, and hypercholesterolemia. More- enlarged hyperchromatic nuclei, nucleoli, mitotic over, these patients have a higher presenting serum figures, and focal apoptosis (Fig 2C). About 40% creatinine level (3.5 versus 1.3 mg/dL and 4.2 of cases may have tubular microcysts that contain versus 2.0 mg/dL) despite a shorter time course loose proteinaceous casts.31 from clinical onset to biopsy examination.30,31 By immunofluorescence there are segmental to Primary FSGS with collapsing features typically global deposits of IgM, C3, and, less commonly, has a rapid course to renal failure and is often C1 in collapsing segments. Visceral epithelial pro- unresponsive to steroid therapy.30-31,38 One group tein resorption droplets often stain for IgG, IgA, found a median renal survival of 13.0 months and albumin, with similar staining in the tubular compared with 62.5 months for controls with clas- epithelial protein droplets. sic FSGS.31 Thus, this variant has been considered At the ultrastructural level, the collapsed lobules the morphologic counterpart of the malignant display wrinkling and little or no thickening of FSGS proposed years earlier by Brown et al16 and GBMs (Fig 5A). The overlying podocytes are Cameron et al.39 markedly hypertrophied with severe foot process Recently, some cases of FSGS with collapsing effacement, focal detachment, and increased num- features have been identified as a form of drug bers of organelles including electron dense protein nephrotoxicity in older patients treated with pam- resorption droplets, electron lucent transport vesi- idronate, an osteoclast inhibitor that reduces bone cles, and rough endoplasmic reticulum. The actin resorption, for myeloma, or carcinoma metastatic cytoskeleton usually appears disrupted, giving the to bone.40 Collapsing FSGS has been reported to cells a relatively open appearing cytoplasm (Fig occur in some patients with viral infections owing 5A). Noncollapsed capillaries also display severe to parvovirus B1941 or SV40,42 suggesting a role foot process effacement. No electron dense depos- for direct viral infection of the kidney. its are observed, with the exception of rare small A collapsing pattern of FSGS may also occur de paramesangial electron densities corresponding to novo or as a recurrent disease in the allograft.43-45 the mesangial deposits of IgM. In contrast to HIV- In this setting, the de novo disease often is unac- associated nephropathy, no tubuloreticular inclu- companied by nephrotic syndrome and appears to sions are identified in idiopathic collapsing FSGS. be a less specific morphologic lesion that does not Collapsing glomerulopathy may be confused necessarily represent primary FSGS. Nadasdy et with forms of crescentic glomerulonephritis. The al45 has reported a zonal distribution of collapsing proliferating podocytes in collapsing FSGS lack FSGS in some allografts with transplant arteriopa- the spindled morphology and pericellular matrix thy, suggesting a role for ischemic injury. These seen surrounding the proliferating parietal cells of findings are reminiscent of the collapsing or cellu- true crescents. Crescentic glomerulonephritis also lar pattern of focal sclerosis observed in some is distinguished by the usual presence of necrotiz- native kidney specimens with ischemia and pro- PATHOLOGIC CLASSIFICATION OF FSGS 127 teinuria on the basis of renovascular hypertension are observed in almost half of the cases.50 Serolo- or cholesterol embolization.46,47 gies for lupus and HIV are negative, serum com- plement levels are normal, and there is no clinical OTHER FORMS OF FSGS evidence of systemic disease. Most cases are ste- Among the entities listed in Table 1, only C1q roid resistant, although some have achieved full nephropathy, HIV-associated nephropathy, and remissions.50 Three-year renal survival was re- secondary FSGS mediated by structural-functional ported at 84% in a cohort of 79 patients.50 adaptations will be discussed in any depth owing to space constraints. HIV-ASSOCIATED NEPHROPATHY

C1q NEPHROPATHY Pathologic Features This controversial entity was first described by HIV-associated nephropathy (HIV-AN) is de- Jennette and Hipp48 in 1985. It is defined as a form fined as a form of focal segmental glomeruloscle- of idiopathic nephrotic syndrome caused by a glo- rosis occurring in HIV-infected patients. The light merulopathy with dominant paramesangial depos- microscopic findings in HIV-associated nephropa- its of C1q (of at least 2ϩ intensity on a scale of thy are qualitatively similar to those described ear- 0–4ϩ). lier in collapsing glomerulopathy.51,52 The charac- teristic lesion is a collapsing sclerosis with Pathologic Features prominent podocyte alterations. As the lesions The pattern by light microscopy is usually one progress, the glomerular tuft may be reduced to an of FSGS with variable mesangial hypercellularity acellular sclerotic ball with crowning of the over- (Fig 3A). Although early reports emphasized the lying podocytes and relative dilatation of the uri- mesangial proliferative features,48 subsequent re- nary space (Fig 3C). A proteinaceous filtrate fre- ports have stressed the resemblance to FSGS.49 quently is identified within the enlarged urinary By immunofluorescence, in addition to staining space (Fig 3C). for C1q (of at least 2ϩ intensity), most cases have Tubular microcysts are common, affecting ap- codeposits of IgG (90%) of mean 1.6 intensity, or proximately 30% to 40% of cases51 (Fig 3C). Some IgM (94%) of mean 1.1 intensity, and C3 (90%) of patients with advanced disease at autopsy have mean 1.1 intensity on a scale of 0 to 4ϩ.50 Deposits almost complete replacement of the cortical paren- of IgA are less common and were observed in 56% chyma by massive microcyst formation. This mi- of biopsy examinations with mean intensity 0.7. crocystic transformation likely contributes to the The mesangial deposits are often comma shaped enlarged kidneys and increased echogenicity by because of their paramesangial location and con- ultrasound observed even in patients with end- formation to the overlying GBM reflection (Fig 3B). stage renal failure. Electron dense deposits are primarily or exclu- The immunofluorescence findings are similar to sively located in the mesangium. In over 90% of those of primary FSGS with collapsing features. cases, electron microscopy reveals prominent Differences between HIV-associated nephropathy paramesangial electron dense deposits located sub- and idiopathic collapsing glomerulopathy are seen jacent to the GBM reflection (Fig 5B). In a minor- only at the ultrastructural level (Figs 5C-5E). The ity of cases, rare subendothelial and subepithelial major distinguishing feature is the abundance of deposits also may be seen. There is prominent but tubuloreticular inclusions in the glomerular endo- variable foot process effacement. thelial cells of HIV-associated nephropathy (Fig 5D).51 Tubuloreticular inclusions, also known as Clinical-Pathologic Features interferon footprints consist of 24-nm interanasta- Many investigators believe that C1q nephropa- mosing tubular structures located within dilated thy represents a morphologic variant of primary cisternae of endoplasmic reticulum. They may be FSGS with similar pathogenesis and outcome.48-50 large and multiple per cell. Although they are Most patients present with idiopathic nephrotic identified most readily in the glomerular endothe- syndrome and renal insufficiency (with mean urine lium, they also occur in arterial or interstitial cap- protein levels of 5.9 g and mean serum creatinine illary endothelial cells as well as infiltrating leuko- levels of 1.5 mg/dL).50 Edema and hypertension cytes. Tubuloreticular inclusions were noted with 128 VIVETTE D’AGATI

Fig 3. Light and fluorescence microscopic findings in C1q nephropathy, HIV-AN, and secondary FSGS. (A) C1q nephropathy. Low-power view showing a characteristic field of focal segmental and global glomerulosclerosis with patchy tubular atrophy and interstitial fibrosis (PAS). (B) C1q nephropathy. There are global comma-shaped deposits of C1q outlining the paramesangial regions (immunofluorescence). (C) HIV-associated nephropathy. There is collapse of the glomerular tuft with dilatation of the urinary space. The tubules are markedly dilated forming microcysts with voluminous proteinaceous casts (PAS). (D) Secondary FSGS caused by obesity. The glomerulus on the left from an obese patient shows marked glomerulomegaly compared with that of an age- and sex-matched nonobese control on the right. (E) Secondary FSGS caused by obesity. There are 2 discrete lesions of segmental sclerosis, one arising from the vascular pole, and the other involving the periphery of the tuft. Note the absence of podocyte reactivity (PAS). (F) Secondary FSGS caused by hypertensive nephrosclerosis. In the subcapsular area there are numerous atubular glomeruli forming glomerular microcysts with shrunken and simplified tuft, dilatation of the urinary space, and proteinaceous filtrate. The adjacent tubules are severely atrophied (PAS). PATHOLOGIC CLASSIFICATION OF FSGS 129

Fig 4. Electron microscopic findings in FSGS (NOS) and FSGS, cellular variant. (A) FSGS (NOS). A lesion of segmental sclerosis with inframembranous hyalinosis, endocapillary foam cells, and podocyte detachment with complete effacement of foot processes. (B) FSGS (NOS). Overlying the segmental lesion there is podocyte detachment with large intracytoplasmic electron lucent transport vesicles. The GBM are wrinkled and the glomer- ular capillaries are obliterated by matrix material. (C) FSGS (NOS). A nonsclerotic segment showing detachment of podocytes with lamellation of neomembrane material. The podocytes are hypertrophied with microvillous trans- formation of their cytoplasm. (D) FSGS, cellular variant. Nonsclerotic capillaries display complete foot process effacement with extensive microvillous transformation. (E) FSGS, cellular variant. The glomerular capillary lumen is obliterated by endocapillary hypercellularity including many foamy cells with clear lipid vacuoles. The overlying podocytes are detached with neomembrane formation. (F) FSGS, cellular variant. The glomerular capillary lumen is engorged with cells, including infiltrating monocytes and foam cells, admixed with inframembranous hyaline. There is marked hypertrophy and hyperplasia of the overlying podocytes. 130 VIVETTE D’AGATI

Fig 5. Electron microscopic findings in FSGS, collapsing variant, C1q nephropathy, HIV-AN, and secondary FSGS caused by obesity. (A) FSGS, collapsing variant. There is tight collapse of the GBMs causing luminal obliteration. Note the marked hypertrophy and hyperplasia of the overlying podocytes with loss of primary processes, complete effacement of foot processes, and podocyte detachment. (B) C1q nephropathy. Electron dense deposits are present in the mesangium. The deposits tend to pool in the paramesangial regions, subjacent to the GBM reflection over the mesangium. There is mild focal foot process effacement. (C) HIV-AN. The GBMs are collapsed with secondary luminal narrowing. The overlying podocytes form a cellular cap with marked hypertrophy and numerous intracytoplasmic protein resorption droplets. (D) HIV-AN. A glomerular endothelial cell contains a large tubuloreticular inclusion located within a cistern of endoplasmic reticulum. (E) HIV-AN. A tubular epithelial cell displays granular degeneration of its nuclear chromatin. (F) Secondary FSGS caused by obesity. The foot processes show minimal effacement involving less than 20% of the glomerular capillary surface area, despite the presence of nephrotic-range proteinuria. PATHOLOGIC CLASSIFICATION OF FSGS 131 frequency in renal biopsy examinations of HIV- York City.53 HIV-AN is predominantly a disease infected patients in the 1980s. However, they may of blacks (90%). Although it can occur in both be far less frequent in the modern era of highly sexes and with any HIV risk factor, it is most active antiretroviral therapy, probably owing to common in male intravenous drug abusers. reduced viral burden (personal observations). Presenting features include proteinuria, usually Other characteristic but relatively less frequent in the nephrotic range, and renal insufficiency. ultrastructural findings include nuclear bodies Despite the high frequency of nephrotic-range pro- within tubular and interstitial cells, granular-fibril- teinuria and hypoalbuminemia, hypercholesterol- lar transformation of the tubular nuclei, and con- emia and edema are relatively uncommon. The fronting cylindrical cisternae (Fig 5E).51 absence of hypercholesterolemia likely reflects the reduced hepatic synthesis of lipoproteins in ac- Differential Diagnosis quired immune deficiency syndrome. Hyperten- The major differential diagnosis is from primary sion is relatively uncommon.54 By ultrasound, the FSGS with collapsing features. HIV serologies are kidneys usually are large and echogenic. required for definitive distinction between these Early reports of HIV-AN described a rapid entities. course to renal failure, with mean time to dialysis Included within the spectrum of HIV-associated of less than 2 months.53 However, in the modern nephropathies are diffuse mesangial hypercellular- era of highly active antiretroviral therapy, reduced ity and minimal change disease, which are more viral load and improved renal survival have been common in HIV-infected children than adults. achieved. After highly active antiretroviral therapy These milder variants usually present with ne- there may be dramatic improvement in the renal phrotic syndrome and normal renal function, with- biopsy findings, with reversal of tubular micro- out the rapid course to renal failure that character- cysts.55 A more detailed description of this entity izes the collapsing form of HIV-associated can be found in the article by Herman and Klotman nephropathy. in this issue. HIV-associated nephropathy must be differenti- ated from a variety of other glomerular and tubu- SECONDARY FSGS lointerstitial diseases that occur in HIV-infected Secondary FSGS denotes the pattern of focal patients.52 One of the most common immune com- and segmental glomerulosclerosis that develops in plex–mediated glomerular lesions is membrano- the course of a number of renal diseases in which proliferative glomerulonephritis, particularly in there is reduced number of functioning nephrons or HIV-infected intravenous drug abusers with hepa- hemodynamic stress on an initially normal nephron titis C virus coinfection. Another common glomer- population (see Table 1).6,7 Secondary FSGS is ular disease in the HIV population is IgA nephrop- most common in the setting of obesity, hyperten- athy, which may be associated with IgA-containing sive nephrosclerosis, sickle cell anemia, and any cryoglobulins. IgA nephropathy has been reported advanced renal process with significant loss of in both HIV-infected blacks and whites. Glomeru- functioning nephrons. lar immune deposits eluted from the glomeruli of some of these patients have shown specificity for Pathologic Features HIV envelope or core proteins. Other glomerular Glomerular hypertrophy is a relatively constant lesions occurring in HIV-infected patients include finding (Fig 3D). Although actual measurements of membranous glomerulopathy, lupus-like glomeru- glomerular diameter are not performed routinely in lonephritis, acute postinfectious glomerulonephri- clinical practice, an experienced renal pathologist tis, and thrombotic microangiopathies. can recognize hypertrophied glomeruli readily by routine light microscopy. As a simple rule of Clinical-Pathologic Correlations thumb, hypertrophied glomeruli usually filla40ϫ The incidence of heroin nephropathy has de- high-dry microscopic field. Because the glomerular creased reciprocally with the advent of HIV-AN in tuft is a sphere, glomerular hypertrophy is best the early 1980s.32 In 1984, a distinctive form of assessed in a plane of section that transects the FSGS occurring in HIV-infected patients was first hilus of the glomerulus, at the epicenter of the described at Downstate Medical Center in New glomerular tuft. The largest glomerular volumes 132 VIVETTE D’AGATI recorded are seen in oligomeganephronia, a con- if any, podocyte reactivity (Fig 3E). FSGS usually genital disorder with markedly reduced nephron develops in the absence of significant background number from birth. tubulointerstitial disease. Mild mesangial sclerosis In forms of secondary FSGS resulting from loss may be seen, resembling the changes of early di- of renal mass, FSGS usually is seen in a back- abetic glomerulosclerosis.57 ground of extensive global glomerulosclerosis with corresponding tubular atrophy and interstitial Pathogenesis fibrosis. Secondary FSGS is often mediated by increased Most forms of secondary FSGS have discrete glomerular capillary pressures and flow rates that segmental scars, often involving the perihilar re- occur as an adaptive response to a reduced number gions of hypertrophied glomeruli (Fig 3E). Podo- of functioning nephrons.7 Increased wall tension cyte hypertrophy and hyperplasia are less frequent causes mechanical stress on the podocyte foot pro- than in primary FSGS (Fig 3E). In secondary cess-GBM connection. This in turn leads to local FSGS, the degree of foot process fusion is gener- dilatation of capillaries and strain on the podo- ally mild, affecting less than 50% of the total cytes.59-61 If the tension on the podocyte is severe glomerular capillary surface area (Fig 5F). Because and prolonged, there is progressive cell body at- of its variability, however, the percentage of foot tenuation, pseudocyst formation, and, ultimately, process fusion cannot be used as an absolute or detachment from the GBM.61 Overload of the ly- specific criterion by which to distinguish primary sosomal system with protein resorption droplets from secondary FSGS. may promote cell autoinjury. In secondary FSGS caused by hypertensive ne- Podocyte detachment is the first committed le- phrosclerosis, there is prominent arteriolosclerosis, sion to segmental sclerosis, leaving bare patches of arteriolar hyalinosis, and arteriosclerosis. Predilec- GBM. The concept of relative podocyte insuffi- tion for glomerular sclerosis to occur in the outer ciency proposed by Kriz explains how these de- cortex with formation of subcapsular scars is ap- nuded segments of GBM come into contact with preciated readily in biopsy specimens in which the parietal epithelial cells, promoting synechiae to renal capsule has been sampled. There is invariably Bowman’s capsule.61 If patent capillaries remain prominent chronic tubulointerstitial disease and caught in the adhesion, a route of filtration into the glomerular hypertrophy. Lesions of segmental periglomerular interstitium toward the tubular pole sclerosis and hyalinosis are often perihilar and can lead to obliteration of the tubular pole and develop in glomeruli that also are hypertrophied. formation of atubular glomeruli with microcystic Most lesions of segmental sclerosis are of the clas- dilatation of Bowman’s capsule.56 sic type, with solidification of the tuft by increased matrix. However, in some cases there also are Clinical-Pathologic Correlations cellular or collapsing features that may mimic Knowledge of the presenting clinical features idiopathic FSGS. This is especially the case in and associated medical conditions is essential to patients with secondary FSGS in the setting of differentiate primary FSGS from secondary FSGS cholesterol embolization or renovascular hyperten- caused by structural-functional adaptations.7 Typ- sion.46,47 A common feature of secondary FSGS ically, patients with secondary FSGS manifest ne- owing to hypertensive nephrosclerosis is the devel- phrotic range or subnephrotic proteinuria without opment of atubular glomeruli with cystic dilatation full nephrotic syndrome. Thus, they may have pro- of Bowman’s space (Fig 3F).56 The tuft is teinuria levels greater than 3.0 g/d, but they usually shrunken and partially resorbed into Bowman’s lack hypoalbuminemia, hypercholesterolemia, and capsule. Atubular glomeruli are most abundant in edema. Because the development of FSGS is often areas of subcapsular scarring with severe tubular a response to a loss of functioning nephrons, most atrophy (Fig 3F). patients have a history of renal insufficiency for In obesity-associated FSGS, there is prominent months or years preceding the development of glomerular hypertrophy and the lesions of focal nephrotic proteinuria. An exception is FSGS sec- sclerosis typically affect a minority of hypertro- ondary to morbid obesity, in which patients often phied glomeruli.57,58 Lesions are characteristically have an initially supernormal glomerular filtration perihilar with associated hyalinosis. There is little, rate, reflecting a hyperfiltration state imposed by an PATHOLOGIC CLASSIFICATION OF FSGS 133 increased ratio of body mass to renal mass.57 The 8. Fogo A, Glick AD, Horn SL, et al: Is focal segmental resulting glomerular overwork is associated with glomerulosclerosis really focal? Distribution of lesions in adults increased renal plasma flow rates, as well as an and children. Kidney Int 47:1690-1696, 1995 9. Yoshikawa N, Ito H, Akamatsu R, et al: Focal segmental elevated glomerular filtration rate. Hypoxia caused glomerulosclerosis with and without nephrotic syndrome in by sleep apnea may play a role in this process by children. J Pediatr 109:65-70, 1986 stimulating the renin-angiotensin system through 10. Southwest Pediatric Nephrology Study Group: Focal sympathetic activation. segmental glomerulosclerosis in children with idiopathic ne- The therapeutic approach to secondary FSGS phrotic syndrome. Kidney Int 27:442-449, 1985 11. Schoeneman MJ, Bennett B, Greifer I: The natural history depends on the underlying condition. Correction of of focal segmental glomerulosclerosis with and without mesangial the underlying process, such as surgical repair of hypercellularity in children. Clin Nephrol 9:45-54, 1978 reflux or congenital heart disease, should be sought 12. Eddy AA, Giachelli CM: Renal expression of genes that where appropriate. In patients with hyperfiltration promote renal interstitial inflammation and fibrosis in rats with caused by reduced renal mass (such as after vesi- protein-overload proteinuria. Kidney Int 47:1546-1557, 1995 coureteral reflux, hypertensive nephrosclerosis, re- 13. Zoja C, Benigni A, Remuzzi G: Protein overload acti- vates proximal tubular cells to release vasoactive and inflam- nal agenesis, and so forth), maneuvers to reduce matory mediators. Exp Nephrol 7:420-428, 1999 glomerular capillary pressures, such as angiotensin 14. Korbet SM: Primary focal segmental glomerulosclerosis. converting enzyme inhibition or angiotensin II re- J Am Soc Nephrol 9:1333-1340, 1998 ceptor blockade are generally offered. Steroids are 15. Velosa J, Holley K, Torres V, et al: Significance of uniformly ineffective in secondary FSGS and may proteinuria on the outcome of renal function in patients with even promote weight gain and progressive sclero- focal segmental glomerulosclerosis. Mayo Clin Proc 58:568- 577, 1983 sis in patients with obesity and latent diabetes. The 16. Brown C, Cameron J, Turner D, et al: Focal segmental course of obesity-related glomerulopathy is gener- glomerulosclerosis with rapid deterioration in renal function ally indolent and few patients progress to end-stage (“malignant FSGS”). Clin Nephrol 10:51-61, 1978 renal disease. In this condition, reductions of pro- 17. Wehrmann M, Bohle A, Held H, et al: Long-term prog- teinuria can be achieved with weight loss, sleep nosis of focal sclerosing glomerulonephritis: Analysis of 250 cases with particular regard to tubulointerstitial changes. Clin apnea therapy, and angiotensin receptor blockade Nephrol 33:115-122, 1990 57 or angiotensin converting enzyme inhibitors. 18. Schwartz MM, Korbet SM: Primary focal segmental glomerulosclerosis: Pathology, histologic variants, and patho- ACKNOWLEDGMENT genesis. Am J Kidney Dis 22:874-883, 1993 The author acknowledges the intellectual contributions of the 19. Schwartz MM, Korbet SM, Rydel JJ, et al. Primary focal members of the consensus conference on the pathologic clas- segmental glomerular sclerosis in adults: Prognostic value of sification of FSGS, including Drs. Jan Bruijn, Agnes Fogo, and histologic variants. Am J Kidney Dis 25:845-852, 1995 J. Charles Jennette. 20. Mongeau JG, Robitaille PO, Clermont MJ, et al: Focal segmental glomerulosclerosis (FSG) 20 years later: From tod- REFERENCES dler to grown up. Clin Nephrol 40:1-6, 1993 1. Fahr T: Pathologische anatomie des morbus brightii, in 21. Schwartz MM, Lewis EJ: Focal segmental glomerular Henke F, Lubarsch O (eds): Handbuch der speziellen patholo- sclerosis: The cellular lesion. Kidney Int 28:968-974, 1985 gischen anatomie und histologie (vol 6). Berlin, Springer, 1925, 22. Korbet SM, Schwartz MM, Lewis EJ: Recurrent ne- p 156 phrotic syndrome in renal allografts. Am J Kidney Dis 11:270- 2. Rich AR: A hitherto undescribed vulnerability of the 276, 1988 juxta-medullary glomeruli in lipoid nephrosis. Bull Johns Hop- 23. Schwartz MM, Evans J, Bain R, et al: Focal segmental kins Hosp 100:173-186, 1957 glomerulosclerosis: Prognostic implication of the cellular le- 3. Churg J, Habib R, White RH: Pathology of the nephrotic sion. J Am Soc Nephrol 10:1900-1907, 1999 syndrome in children: A report for the International Study of 24. Howie AJ, Brewer DB: The glomerular tip lesion: A in Children. Lancet 760:1299-1302, 1970 previously undescribed type of segmental glomerular abnormal- 4. Habib R: Focal glomerulosclerosis. Kidney Int 4:355-361, ity. J Pathol 142:205-220, 1984 1973 25. Huppes W, Hene RJ, Kooiker CJ: The glomerular tip 5. Southwest Pediatric Nephrology Study Group: Focal seg- lesion: A distinct entity or not? J Pathol 154:187-190, 1988 mental glomerulosclerosis in children with idiopathic nephrotic 26. Haas M, Yousefzadeh N: Glomerular tip lesion in min- syndrome. Kidney Int 27:442-449, 1985 imal change nephropathy: A study of autopsies before 1950. 6. D’Agati V: The many masks of focal segmental glomer- Am J Kidney Dis 39:1168-1175, 2002 ulosclerosis. Kidney Int 46:1223-1241, 1994 27. Beaman M, Howie AJ, Hardwicke J, et al: The glomer- 7. Rennke H, Klein PS: Pathogenesis and significance of ular tip lesion; a steroid responsive nephrotic syndrome. Clin non-primary focal and segmental glomerulosclerosis. Am J Nephrol 27:217-221, 1987 Kidney Dis 13:443-455, 1989 28. Hogan-Moulton A, Hogan S, Falk R, et al: Glomerular 134 VIVETTE D’AGATI tip lesion: Clinical features, response to corticosteroids and collapsing glomerulopathy in renal allografts. Transplantation comparison to FSGS. J Am Soc Nephrol 8:87A, 1997 65:1192-1197, 1998 29. Weiss MA, Daquioag E, Margolin EG, et al: Nephrotic 45. Nadasdy T, Allen C, Zand MS: Zonal distribution of syndrome, progressive irreversible renal failure, and glomerular glomerular collapse in renal allografts: Possible role of vascular “collapse.” A new clinico-pathologic entity? Am J Kidney Dis changes. Hum Pathol 33:437-441, 2002 7:20-28, 1986 46. Greenberg A, Bastacky SL, Iqbal A, et al: Focal seg- 30. Detwiler RK, Falk RJ, Hogan SL, et al: Collapsing mental glomerulosclerosis associated with nephrotic syndrome glomerulopathy: A clinically and pathologically distinct variant in cholesterol embolization: Clinicopathologic correlations. of focal segmental glomerulosclerosis. Kidney Int 45:1416- Am J Kidney Dis 29:334-344, 1997 1424, 1994 47. Thadhani R, Pascual M, Nickeleit V, et al: Preliminary 31. Valeri A, Barisoni L, Appel GB, et al: Idiopathic col- description of focal segmental glomerulosclerosis in patients lapsing focal segmental glomerulosclerosis: A clinico-patho- with renovascular disease. Lancet 347:231-233, 1996 logic study. Kidney Int 50:1734-1746, 1996 48. Jennette JC, Hipp CG: C1q nephropathy: A distinct 32. Barisoni L, D’Agati V: The changing epidemiology of pathologic entity usually causing nephrotic syndrome. Am J focal segmental glomerulosclerosis in New York City. Mod Kidney Dis 6:103-110, 1985 Pathol 7:156A, 1994 49. Iskandar SS, Browning MC, Lorentz WB: C1q nephrop- 33. Barisoni L, Kriz W, Mundel P, et al: The dysregulated athy: A pediatric clinicopathologic study. Am J Kidney Dis podocyte phenotype; a novel concept in the pathogenesis of 18:459-465, 1991 collapsing idiopathic focal segmental glomerulosclerosis and 50. Jennette JC, Wilkman AS, Hogan SL, et al: Clinical and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61, pathologic features of C1q nephropathy. J Am Soc Nephrol 1999 4:681, 1993 34. Shankland SJ, Eitner F, Hudkins KL, et al: Differential 51. D’Agati V, Suh J-I, Carbone L, et al: Pathology of expression of cyclin-dependent kinase inhibitors in human glo- HIV-associated nephropathy: A detailed morphologic and com- merular disease: Role in podocyte proliferation and maturation. parative study. Kidney Int 35:1358-1370, 1989 Kidney Int 58:674-683, 2000 52. D’Agati V, Appel GB: Renal pathology of human im- 35. Barisoni L, Mokrzycki M, Sablay L, et al: Podocyte cell munodeficiency virus infection. Semin Nephrol 18:406-421, cycle regulation and proliferation in collapsing glomerulopa- 1998 thies. Kidney Int 58:137-143, 2000 53. Rao TK , Filippone EJ, Nicastri AD, et al: Associated 36. Bariety J, Nochy D, Mandet C, et al: Podocytes undergo focal and segmental glomerulosclerosis in the acquired immu- phenotypic changes and express macrophagic-associated mark- nodeficiency syndrome. N Engl J Med 310:669-673, 1984 ers in idiopathic collapsing glomerulopathy. Kidney Int 53:918- 54. Carbone L, D’Agati V, Cheng JT, et al: The course and 928, 1998 prognosis of human immunodeficiency virus-associated ne- 37. Bariety J, Bruneval P, Hill G, et al: Post-transplantation phropathy. Am J Med 87:389-395, 1989 relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 12:261-274, 2001 55. Winston JA, Bruggeman LA, Ross MD, et al: Nephrop- 38. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing athy and establishment of a renal reservoir of HIV type 1 during glomerulopathy in HIV and non-HIV patients: A clinicopatho- primary infection. N Engl J Med 344:1979-1984, 2001 logical and follow-up study. Kidney Int 56:2203-2213, 1999 56. Kriz W, Hosser H, Hahnel B, et al: From segmental 39. Cameron JS, Turner DR, Ogg CS, et al: The long-term glomerulosclerosis to total nephron degeneration and interstitial prognosis of patients with focal segmental glomerulosclerosis. fibrosis: A histopathologic study in rat models and human Clin Nephrol 10:213-218, 1978 glomerulopathies. Nephrol Dial Transplant 13:2781-2798, 1998 40. Markowitz GS, Appel GB, Fine PL, et al: Collapsing 57. Kambham N, Markowitz GS, Valeri AM, et al: Obesity- focal segmental glomerulosclerosis following high dose pam- related glomerulopathy: An emerging epidemic. Kidney Int idronate. J Am Soc Nephrol 12:1164-1172, 2001 59:1498-1509, 2001 41. Moudgil A, Nast CC, Bagga A, et al: Association of 58. Verani RR: Obesity-associated focal segmental glomer- parvovirus B19 infection with idiopathic collapsing glomeru- ulosclerosis: Pathologic features of the lesion and relationship lopathy. Kidney Int 59:2126-2133, 2001 with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20: 42. Li R-M, Branton MH, Tanawattanacharoen S, et al: 629-634, 1992 Molecular identification of SV40 infection in human subjects 59. Kriz W, Gretz N, Lemley KV: Progression of glomerular and possible association with kidney disease. J Am Soc Nephrol diseases: Is the podocyte the culprit? 54:687-697, 1998 13:2320-2330, 2002 60. Kriz W, Elger M, Nagata M, et al: The role of podocytes 43. Stokes MB, Davis CL, Alpers CE: Collapsing glomeru- in the development of glomerular sclerosis. Kidney Int 45:S64- lopathy in renal allografts: A morphological pattern with di- S72, 1994 (suppl 45) verse clinicopathologic associations. Am J Kidney Dis 33:658- 61. Nagata M, Kriz W: Glomerular damage after unine- 666, 1999 phrectomy in young rats. II. Mechanical stress on podocytes as 44. Meehan SM, Pascual M, Williams WW, et al: De novo a pathway to sclerosis. Kidney Int 42:148-160, 1992